Skip to main content

Milestone 9.C

Initiate development of imaging and/or fluid biomarkers to demonstrate target engagement for 5 novel therapeutic targets for AD and related dementias.

Success Criteria

Identification of 3 imaging and/or fluid biomarkers for which there is proof of engagement of novel therapeutic targets.

Time Required

2014 to 2018

Research Implementation Area


Activities, Funding Initiatives, and Resources

NIH PAR-15-359: Novel Approaches to Diagnosing Alzheimer's Disease & Predicting…

Relevant Recommendation(s)

2012 AD Summit Recommendations: 1E